Runben Biotechnology Co (603193.SS) Stock Price

Runben Biotechnology Co Price

CLOSED
21.12CNY+0.33 (+1.57 %)
Market closed

Over the last 2 years Runben Biotechnology Co grew revenue by 24.1% annually, reaching 1.32 B CNY. Earnings per share have grown at 36.9% per year over the last 2 years. For Runben Biotechnology Co, the net margin of 22.8% is up versus 18.7% a few years ago. At today's price the dividend yield works out to roughly 1.66%. The payout ratio is around 47% of earnings. The consensus 12-month price target for Runben Biotechnology Co is 37.13 CNY, about 75.8% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 15% above its 52-week low.

Runben Biotechnology Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Runben Biotechnology Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Runben Biotechnology Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Runben Biotechnology Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Runben Biotechnology Co Stock Price History
DateRunben Biotechnology Co Price
8/10/202621.12 CNY
8/7/202620.79 CNY
8/6/202621.13 CNY
8/5/202621.32 CNY
8/4/202621.40 CNY
8/3/202621.81 CNY
7/31/202621.96 CNY
7/30/202622.56 CNY
7/29/202622.07 CNY
7/28/202620.89 CNY
7/27/202619.57 CNY
7/24/202618.74 CNY
7/23/202619.52 CNY
7/22/202619.37 CNY
7/21/202619.32 CNY
7/20/202619.41 CNY
7/17/202619.30 CNY
7/16/202619.65 CNY
7/15/202619.24 CNY
7/14/202618.45 CNY
7/13/202618.51 CNY
7/10/202618.67 CNY
7/9/202618.56 CNY
7/8/202618.84 CNY
7/7/202618.82 CNY
7/6/202619.29 CNY
7/3/202619.57 CNY
7/2/202619.24 CNY
7/1/202618.88 CNY
6/30/202618.55 CNY
6/29/202618.70 CNY
6/26/202618.34 CNY
6/25/202618.77 CNY
6/24/202619.33 CNY
6/23/202620.25 CNY
6/22/202619.67 CNY
6/18/202620.87 CNY
6/17/202620.68 CNY
6/16/202621.11 CNY
6/15/202621.56 CNY
6/12/202621.45 CNY
6/11/202621.07 CNY
6/10/202621.60 CNY
6/9/202621.42 CNY
6/8/202621.70 CNY
6/5/202622.92 CNY
6/4/202622.48 CNY
6/3/202623.17 CNY
6/2/202623.45 CNY
6/1/202623.23 CNY
5/29/202622.04 CNY
5/28/202621.78 CNY
5/27/202621.98 CNY
5/26/202622.56 CNY
5/25/202623.01 CNY
5/22/202623.06 CNY
5/21/202623.82 CNY
5/20/202623.36 CNY
5/19/202623.77 CNY
5/18/202623.51 CNY
5/15/202624.12 CNY
5/14/202624.03 CNY
5/13/202625.10 CNY
5/12/202624.94 CNY
5/11/202625.08 CNY
5/8/202625.69 CNY
5/7/202626.12 CNY
5/6/202626.62 CNY
4/30/202625.97 CNY
4/29/202626.13 CNY
4/28/202626.16 CNY
4/27/202626.58 CNY
4/24/202626.21 CNY
4/23/202626.04 CNY
4/22/202624.58 CNY
4/21/202625.05 CNY
4/20/202625.49 CNY
4/17/202624.38 CNY
4/16/202624.61 CNY
4/15/202624.51 CNY
4/14/202623.85 CNY
4/13/202624.13 CNY
4/10/202624.94 CNY
4/9/202625.03 CNY
4/8/202625.30 CNY
4/7/202623.95 CNY
4/3/202624.14 CNY
4/2/202623.59 CNY
4/1/202624.46 CNY
3/31/202622.24 CNY
3/30/202621.39 CNY
3/27/202621.16 CNY
3/26/202620.84 CNY
3/25/202621.05 CNY
3/24/202620.95 CNY
3/23/202620.38 CNY
3/20/202621.57 CNY
3/19/202621.93 CNY
3/18/202622.40 CNY
3/17/202622.52 CNY
3/16/202622.73 CNY
3/13/202622.38 CNY
3/12/202622.38 CNY
3/11/202622.60 CNY
3/10/202622.58 CNY
3/9/202622.37 CNY
3/6/202622.55 CNY
3/5/202622.00 CNY
3/4/202621.97 CNY
3/3/202622.32 CNY
3/2/202622.78 CNY
2/27/202623.46 CNY
2/26/202623.32 CNY
2/25/202623.55 CNY
2/24/202623.44 CNY
2/13/202623.23 CNY
2/12/202623.61 CNY
2/11/202623.93 CNY
2/10/202623.92 CNY
2/9/202623.98 CNY
2/6/202623.85 CNY
2/5/202624.20 CNY
2/4/202623.80 CNY
2/3/202623.59 CNY
2/2/202623.44 CNY
1/30/202623.84 CNY
1/29/202623.93 CNY
1/28/202623.84 CNY
1/27/202624.38 CNY
1/26/202625.29 CNY
1/23/202625.71 CNY
1/22/202625.26 CNY
1/21/202625.45 CNY
1/20/202625.35 CNY
1/19/202624.93 CNY
1/16/202624.73 CNY
1/15/202624.85 CNY
1/14/202624.88 CNY
1/13/202625.00 CNY
1/12/202625.33 CNY
1/9/202624.98 CNY
1/8/202624.84 CNY
1/7/202624.73 CNY
1/6/202624.82 CNY
1/5/202624.69 CNY
12/31/202524.23 CNY
12/30/202524.20 CNY
12/29/202524.28 CNY
12/26/202524.47 CNY
12/25/202524.72 CNY
12/24/202524.38 CNY
12/23/202524.34 CNY
12/22/202524.67 CNY
12/19/202524.96 CNY
12/18/202524.72 CNY
12/17/202524.37 CNY
12/16/202524.59 CNY
12/15/202524.67 CNY
12/12/202524.24 CNY
12/11/202524.04 CNY
12/10/202524.37 CNY
12/9/202524.13 CNY
12/8/202524.36 CNY
12/5/202524.03 CNY
12/4/202523.99 CNY
12/3/202524.82 CNY
12/2/202525.34 CNY
12/1/202525.62 CNY
11/28/202525.34 CNY
11/27/202525.50 CNY
11/26/202525.63 CNY
11/25/202525.84 CNY
11/24/202525.44 CNY
11/21/202525.82 CNY
11/20/202524.60 CNY
11/19/202524.91 CNY
11/18/202525.44 CNY
11/17/202525.48 CNY
11/14/202525.74 CNY
11/13/202525.95 CNY
11/12/202525.95 CNY
11/11/202525.99 CNY
11/10/202525.96 CNY
11/7/202525.45 CNY
11/6/202525.79 CNY
11/5/202526.28 CNY
11/4/202526.18 CNY
11/3/202526.57 CNY
10/31/202526.55 CNY
10/30/202526.26 CNY
10/29/202526.48 CNY
10/28/202526.53 CNY
10/27/202526.50 CNY
10/24/202526.48 CNY
10/23/202526.54 CNY
10/22/202526.44 CNY
10/21/202526.93 CNY
10/20/202528.08 CNY
10/17/202527.27 CNY
10/16/202527.26 CNY
10/15/202527.62 CNY
10/14/202527.19 CNY
10/13/202527.25 CNY
10/10/202528.01 CNY
10/9/202528.03 CNY
9/30/202528.01 CNY
9/29/202528.53 CNY
9/26/202529.38 CNY
9/25/202529.81 CNY
9/24/202529.21 CNY
9/23/202529.35 CNY
9/22/202528.54 CNY
9/19/202528.15 CNY
9/18/202528.31 CNY
9/17/202528.77 CNY
9/16/202528.88 CNY
9/15/202528.25 CNY
9/12/202529.01 CNY
9/11/202528.94 CNY
9/10/202528.93 CNY
9/9/202529.24 CNY
9/8/202529.66 CNY
9/5/202529.48 CNY
9/4/202529.15 CNY
9/3/202528.69 CNY
9/2/202529.09 CNY
9/1/202529.47 CNY
8/29/202529.70 CNY
8/28/202530.28 CNY
8/27/202529.67 CNY
8/26/202530.51 CNY
8/25/202530.59 CNY
8/22/202531.14 CNY
8/21/202530.77 CNY
8/20/202530.88 CNY
8/19/202530.79 CNY
8/18/202531.89 CNY
8/15/202531.92 CNY
8/14/202531.99 CNY
8/13/202531.50 CNY
Access this data via the Eulerpool API
Get Free API Key

Runben Biotechnology Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
856.09 M CNY
179.00 M CNY
160.04 M CNY
Jan 1, 2023
1.03 B CNY
248.39 M CNY
226.03 M CNY
Jan 1, 2024
1.32 B CNY
309.31 M CNY
300.16 M CNY
Jan 1, 2025 (e)
1.55 B CNY
382.25 M CNY
315.58 M CNY
Jan 1, 2026 (e)
1.87 B CNY
461.07 M CNY
378.63 M CNY
Jan 1, 2027 (e)
2.22 B CNY
546.55 M CNY
447.75 M CNY
Jan 1, 2028 (e)
2.60 B CNY
639.85 M CNY
523.03 M CNY

Runben Biotechnology Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 12, 2026, 10:32 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
2022202320242025e2026e2027e2028e
0.861.031.321.551.872.222.60
–20.5627.7117.7520.6218.5417.08
53.9756.1057.9757.9757.9757.9757.97
0.460.580.760.901.091.291.51
178.00248.00309.00382.00461.00546.00639.00
20.7924.0323.4424.6124.6324.6124.60
160.00226.00300.00315.00378.00447.00523.00
–41.2532.745.0020.0018.2517.00
––0.350.430.520.62–
–––22.8620.9319.23–
404.59404.59404.59404.59404.59404.59404.59
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Runben Biotechnology Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Runben Biotechnology Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Runben Biotechnology Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Runben Biotechnology Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Runben Biotechnology Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Runben Biotechnology Co stock margins

The Runben Biotechnology Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Runben Biotechnology Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Runben Biotechnology Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
54.06 %
20.91 %
18.69 %
Jan 1, 2023
56.11 %
24.05 %
21.88 %
Jan 1, 2024
58.03 %
23.47 %
22.77 %
Jan 1, 2025 (e)
58.03 %
24.63 %
20.33 %
Jan 1, 2026 (e)
58.03 %
24.63 %
20.22 %
Jan 1, 2027 (e)
58.03 %
24.63 %
20.18 %

Runben Biotechnology Co Stock Revenue, EBIT, Earnings per Share

The Runben Biotechnology Co earnings per share therefore indicates how much revenue Runben Biotechnology Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2022
2.12 CNY
0.44 CNY
0.40 CNY
Jan 1, 2023
2.55 CNY
0.61 CNY
0.56 CNY
Jan 1, 2024
3.26 CNY
0.76 CNY
0.74 CNY
Jan 1, 2025 (e)
3.84 CNY
0.94 CNY
0.78 CNY
Jan 1, 2026 (e)
4.63 CNY
1.14 CNY
0.94 CNY
Jan 1, 2027 (e)
5.49 CNY
1.35 CNY
1.11 CNY

Runben Biotechnology Co business model & stock analysis

Runben Biotechnology Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Runben Biotechnology Co historical P/E ratio, EBIT multiple, and P/S ratio

Runben Biotechnology Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Runben Biotechnology Co shares outstanding

The number of shares of Runben Biotechnology Co was 404.59 M in 2025. This indicates how many shares Runben Biotechnology Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
404.59 M Stocks
Jan 1, 2023
404.59 M Stocks
Jan 1, 2024
404.59 M Stocks
Jan 1, 2025 (e)
404.59 M Stocks
Jan 1, 2026 (e)
404.59 M Stocks
Jan 1, 2027 (e)
404.59 M Stocks

Runben Biotechnology Co Dividend History

3 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.26CNYYTD—1×
May 29, 20260.26CNY↑ 30.0%1/1
20250.43CNY↑ 22.9%2×
May 30, 20250.23CNY↑ 27.8%1/2
Sep 18, 20250.20CNY↓ 13.0%2/2
20240.35CNY—2×

Runben Biotechnology Co dividend history and estimates

In 2025, Runben Biotechnology Co paid a dividend amounting to 0.43 CNY. Dividend means that Runben Biotechnology Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2024
0.35 CNY
0.00 CNY
0.00 CNY
Jan 1, 2025
0.43 CNY
0.00 CNY
0.00 CNY
Jan 1, 2026 (e)
0.00 CNY
0.52 CNY
0.00 CNY
Jan 1, 2027 (e)
0.00 CNY
0.62 CNY
0.23 CNY

Runben Biotechnology Co dividend payout ratio

In 2025, Runben Biotechnology Co had a payout ratio of 55.13%. The payout ratio indicates the percentage of the company's profits that Runben Biotechnology Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2022
47.18 %
Jan 1, 2023
47.18 %
Jan 1, 2024
47.18 %
Jan 1, 2025 (e)
55.13 %
Jan 1, 2026 (e)
55.14 %
Jan 1, 2027 (e)
55.95 %

Current Runben Biotechnology Co forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
88.89 % (8)
Hold
11.11 % (1)
Sell
0.00 % (0)
12M Price Target
37.13
Last Price
21.58
Currency
CNY
12M Return Potential
72.05 %
LTM Return
0 %

Runben Biotechnology Co shareholder structure

% Name
44.58514%
Guangzhou Zhuofan Investment Holding Co., Ltd.
Guangzhou Zhuofan Investment Holding Co., Ltd.
17.92481%
Zhao (Guiqin)
Zhao (Guiqin)
5.29425%
Guangzhou Zhuofan Chengguang Investment Consulting Partnership LP
Guangzhou Zhuofan Chengguang Investment Consulting Partnership LP
4.76482%
Bao (Songjuan)
Bao (Songjuan)
4.60816%
JNRY Viii HK Holdings Limited
JNRY Viii HK Holdings Limited
1.13448%
Zhao (Hanqiu)
Zhao (Hanqiu)

Runben Biotechnology Co Beneficial Ownership Filings (SEC 13D/G)

Free Float
100.0%
Float Shares
-
Shares Outstanding
-

Frequently asked questions about Runben Biotechnology Co

Analysts currently set an average price target of 39.60 CNY for the Runben Biotechnology Co stock (median: 37.13 CNY), implying +83.5 % versus the latest price. The consensus is based on 9 analyst ratings.

Runben Biotechnology Co Analyst Price Targets 2026

9 analysts currently rate the Runben Biotechnology Co stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Runben Biotechnology Co to generate revenue of 1.87 B CNY and earnings per share of 0.94 CNY.

Runben Biotechnology Co Analyst Price Targets 2026

Converted at the current exchange rate, the Runben Biotechnology Co share trades at 2.71 EUR (21.12 CNY).

No history available for Runben Biotechnology Co.

The expected revenue of Runben Biotechnology Co is 1.87 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Runben Biotechnology Co is 378.63 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Runben Biotechnology Co is currently 22.57. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Runben Biotechnology Co stock.

The price-to-sales ratio (P/S) of Runben Biotechnology Co is currently 4.56. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Runben Biotechnology Co stock.

The Eulerpool Quality Score for Runben Biotechnology Co is 3/10.

The ISIN of Runben Biotechnology Co is CNE100006DK5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Runben Biotechnology Co is 603193.SS. The ticker symbol is used to trade Runben Biotechnology Co shares on the stock exchange.

Over the past 12 months, Runben Biotechnology Co paid a dividend of 0.35 CNY . This corresponds to a dividend yield of about 1.66 %. For the coming 12 months, Runben Biotechnology Co is expected to pay a dividend of 0.62 CNY.

The current dividend yield of Runben Biotechnology Co is 1.66 %.

Runben Biotechnology Co pays a dividend, distributed in the months of , , , .

Runben Biotechnology Co paid dividends every year for the past 2 years.

For the upcoming 12 months, dividends amounting to 0.62 CNY are expected. This corresponds to a dividend yield of 2.93 %.

Runben Biotechnology Co is assigned to the 'Non-cyclical consumption' sector.

In the year 2025, Runben Biotechnology Co distributed 0.35 CNY as dividends.

The dividends of Runben Biotechnology Co are distributed in CNY.

All fundamentals and in-depth analysis of Runben Biotechnology Co

Our stock analysis for Runben Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Runben Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Runben Biotechnology Co Stock
Runben Biotechnology Co Revenue→
Runben Biotechnology Co Stock
Runben Biotechnology Co Net Income→
Runben Biotechnology Co Stock
Runben Biotechnology Co P/E→
Runben Biotechnology Co Stock
Runben Biotechnology Co P/S→
Runben Biotechnology Co Stock
Runben Biotechnology Co EBIT→
Runben Biotechnology Co Stock
Runben Biotechnology Co Dividend→
Runben Biotechnology Co Stock
Runben Biotechnology Co Directors Dealings→
Runben Biotechnology Co Stock
Runben Biotechnology Co Stocks→
Runben Biotechnology Co Stock
Runben Biotechnology Co Market capitalization→
Runben Biotechnology Co Stock
Runben Biotechnology Co Debt→
Runben Biotechnology Co Stock
Runben Biotechnology Co Liabilities→
Runben Biotechnology Co Stock
Runben Biotechnology Co Equity→
Runben Biotechnology Co Stock
Runben Biotechnology Co AAQS→
Runben Biotechnology Co Stock
Runben Biotechnology Co Employees→
Runben Biotechnology Co Stock
Runben Biotechnology Co ROE→
Runben Biotechnology Co Stock
Runben Biotechnology Co ROA→
Runben Biotechnology Co Stock
Runben Biotechnology Co ROCE→
Runben Biotechnology Co Stock
Runben Biotechnology Co News→
Runben Biotechnology Co Stock
Runben Biotechnology Co Analyst Price Targets→

Non-cyclical consumption Stocks

RushnetRuchi InfrastructureS & T CorporationRR Metalmakers IndiaS FoodsRoyal Unibrew A/SS Khonkaen Foods PCLRoyal Plus PCLS.Ishimitsu & CoRoyal Group CoS&B FoodsRossell IndiaAll Stocks A–Z →